Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial.

Rastelli, Antonella L; Taylor, Marie E; Gao, Feng; Armamento-Villareal, Reina; Jamalabadi-Majidi, Shohreh; Napoli, Nicola; Ellis, Matthew J

Rastelli, Antonella L; Taylor, Marie E; Gao, Feng; Armamento-Villareal, Reina; Jamalabadi-Majidi, Shohreh; Napoli, Nicola; Ellis, Matthew J.

Affiliation

Rastelli AL; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. arastell@dom.wustl.edu

Breast Cancer Res Treat ; 129(1): 107-16, 2011 Aug.

Article in En | MEDLINE | ID: mdl-21691817

Subject(s)

Antineoplastic Agents, Hormonal/adverse effects; Aromatase Inhibitors/adverse effects; Bone Density Conservation Agents/therapeutic use; Breast Neoplasms/drug therapy; Ergocalciferols/therapeutic use; Musculoskeletal Diseases/chemically induced; Musculoskeletal Diseases/drug therapy; Nitriles/adverse effects; Triazoles/adverse effects; Aged; Anastrozole; Bone Density/drug effects; Bone Density Conservation Agents/administration & dosage; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Calcium/urine; Ergocalciferols/administration & dosage; Female; Humans; Middle Aged; Musculoskeletal Diseases/metabolism; Pain/drug therapy; Parathyroid Hormone/blood; Vitamin D/analogs & derivatives; Vitamin D/blood

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Triazoles / Breast Neoplasms / Ergocalciferols / Musculoskeletal Diseases / Antineoplastic Agents, Hormonal / Aromatase Inhibitors / Bone Density Conservation Agents / Nitriles Type of study: Clinical_trials / Diagnostic_studies Language: En Journal: Breast Cancer Res Treat Year: 2011 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google